P221 - PREVALENCE OF OVERWEIGHT AND OBESITY IN MOROCCAN WOMEN TREATED FOR ENDOMETRIAL CANCER

P221

PREVALENCE OF OVERWEIGHT AND OBESITY IN MOROCCAN WOMEN TREATED FOR ENDOMETRIAL CANCER

S. Ichou^1,2,*, I. Lahlali^1,2, I. Skitioui^1,2, K. Nouni^1,2, A. Lachgar^1,2, H. Elkacemi^1,2, T. Kebdani^1,2, K. Hassouni^1,2

¹Radiation therapy, National Institut of Oncology, ²Medicine, Faculty of Medicine and Pharmacy, Rabat, Morocco

Rationale: The prevalence of obesity among women with endometrial cancer is a critical health issue, as it is known to influence both the development and prognosis of the disease.

This study aims to assess the prevalence of obesity in Moroccan women who have received treatment for endometrial cancer.

Methods: This is a cross-sectional study of patients with endometrial cancer treated at our brachytherapy departement in the National Oncology center in Rabat, Morocco between 2023 and 2024. Data on demographic characteristics, body mass index (BMI), comorbidities, and treatment related were collected and analyzed using Jamovi.

Results: This study included 30 patients, with a median age of 61 years (± 9.67). Of these, 30% were monitored for conditions such as diabetes and hypertension, and two patients were being treated for ischemic heart disease. All participants were housewives and reported not engaging in any regular physical activity.

All patients reported diets rich in starchy foods, poultry, and sugar.

56.67% of the women in the study were overweight with an average BMI of 27.7 and 20% were found to be obese with an average BMI of 30,2.

All patients received concomitant chemoradiation therapy and brachytherapy. Fourteen patients underwent adjuvant chemotherapy: three for clear cell adenocarcinoma, five for high-grade endometrioid adenocarcinoma, and three for positive tumor margins and four for mutated p53.

Conclusion: This finding highlights the need for targeted public health strategies to address obesity and its impact on cancer outcomes in Morocco. The study also emphasizes the importance of early screening and intervention for obesity in the management of endometrial cancer, as well as the potential benefits of weight management programs for improving prognosis and overall quality of life in affected women.

Disclosure of Interest: None declared